// App-Quantinova.ai

1657 : Salivary Alpha-Synuclein and tau in Parkinson’s Disease and Progressive Supranuclear Palsy

Researchers

Presenter

  • G. Vivacqua

Principal Investigators

  • A. Fabbrini

  • R. Mancinelli

  • D. Belvisi

  • G. Fabbrini

  • A. Suppa

  • A. Berardelli

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Progressive supranuclear palsy

  • Parkinson's disease

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved